click here to return to homepage
 
 

Acceava®, BinaxNOW®, Clearview®, RUBELLA-plus® are registered trademarks of the Inverness Medical family of companies

More Information

TOX A/B Quick Chek

TOX A/B QUIK CHEK® has a larger sample well to make testing for C. difficile toxins A and B fast, easy, accurate, and clean.

Easy to Use

  • A larger sample well means neater, quicker placement.

  • Novel patent-pending technology smoothly disperses sample within the device.

  • The chance of clogging is minimized, greatly reducing unwanted spillovers.


Easy to Read

  • Two lines mean C. difficile toxin A/B is present

  • Internal control line validates the QC result in the same reaction window

Highly Accurate

  • >90% sensitivity*

  • >99% specificity*

 

TOX A/B QUIK CHEK® Testing Procedure

Download sample Procedure Card

 

About C. difficile

Clostridium difficile is a gram-positive, spore-forming anaerobic bacterium. C. difficile is the leading cause of diarrhea outbreaks or C. difficile-associated disease (CDAD) in hospitals, infirmaries, and elderly care units. CDAD is usually caused by antibiotic or chemotherapy disturbing the normal balance of the gut flora.1 Virtually any antibiotic is capable of causing the condition and studies have shown reduced antibiotic prescription levels can significantly reduce CDAD cases.2 Outbreaks in nosocomial environments are difficult to control since the bacteria produces spores that are difficult to eradicate.2

C. difficile has been identified as the organism responsible for toxin production.3 C. difficile produces two large molecular weight toxins, designated A and B. Toxin A is considered to play a more important role in the etiology of CDAD.4 The toxins produce symptoms in CDAD patients, which can range from mild diarrhea to pseudomembranous colitis (PMC). PMC manifests as adherent yellowish-white plaques on the intestinal mucosa. Rapid diagnosis of C. difficile is therefore important in order to treat patients and prevent spread of the disease.2


References

  1. Hamm L. Clostridium difficile. Pediatr Pharm. 2000;6(6).

  2. McNulty C, Logan M, Donald IP, et al. Successful control of Clostridium difficile in an elderly care unit through use of a restrictive antibiotic policy. J Antimicrob Chemother. 1997; 40:707-711.

Specifications
Order No. 30394
Qty: 25 Tests
CPT*: 87803, 87324
CLIA: Non-waived
Contact: (800) 257-9525
TOX A/B Quick Chek
Product Demonstration
Useful Downloads
Product Brochure
Reimbursement
Look up CPT & ICD-9 codes, coverage policies, and state by state Medicare reimbursement information at: www.codemap.com/
inverness
 or call the CodeMap Hotline: 847.381.5465 x5, or email: customerservice@
codemap.com


*It is always the provider's responsibility to establish appropriate coding & charges.
For technical information including: CLSI procedures, Material Safety Data Sheets (MSDS) and package inserts,
call Technical Services at 800-257-9525





Please note that individual products may have different specifications in various markets. Also, some products may not be available in all markets worldwide. The products on this website are available in the United States of America.